FDA approves GSK’s anemia drug with safety warning — after batting back similar drugs
Last calendar year provided a disappointing extend for biotech, with less discounts than expected and heaps far more headwinds. Endpoints Information Editor-in-Chief John Carroll sat down with some of the…